Superior immune reconstitution using Treg-expanded donor cells versus PTCy treatment in preclinical HSCT models

Posttransplant cyclophosphamide (PTCy) has been found to be effective in ameliorating acute graft-versus-host disease (GVHD) in patients following allogeneic hematopoietic stem cell transplantation (aHSCT). Adoptive transfer of high numbers of donor Tregs in experimental aHSCT has shown promise as a...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:JCI Insight
Huvudupphovsmän: Wolf, Dietlinde, Bader, Cameron S., Barreras, Henry, Copsel, Sabrina, Pfeiffer, Brent J., Lightbourn, Casey O., Altman, Norman H., Komanduri, Krishna V., Levy, Robert B.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Clinical Investigation 2018
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6237457/
https://ncbi.nlm.nih.gov/pubmed/30333311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.121717
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk